• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Philips Respironics CPAP, BiPAP mask recall is Class I

Philips Respironics CPAP, BiPAP mask recall is Class I

October 19, 2022 By Sean Whooley

Philips Respironics Recall cpap bipap
[Image from FDA]
The FDA today issued a notice confirming that a recall of Philips (NYSE:PHG) Respironics face masks is Class I, the most serious kind.

Last month, Philips provided an update on an issue with its CPAP and BiPap masks. The Respironics subsidiary alerted users of CPAP or BiPAP therapy masks with magnetic headgear clips or straps. The devices could negatively interact with implantable, metallic medical devices.

Respironics has distributed more than 17 million masks containing magnetic clips. As of Aug. 30, the company received 14 reports suggesting that the maks may have impacted implanted devices. The affected masks include the Amara View full face mask, the DreamWisp nasal mask, the DreamWear full face mask, the Wisp and Wisp Youth nasal mask and the Therapy Mask 3100 NC/SP.

According to the FDA, Philips recalled nearly 18.7 million units in the U.S. since initiating the recall on Aug. 2. It distributed the devices between Jan. 1, 2015, and Sept. 9, 2022. As of Sept. 9, Philips received 43 complaints. Fourteen of those represented serious injuries associated with the issue. It received no reports of associated deaths.

More about the recall

Patients received instructions to stop using the affected masks if the implant/device is contraindicated against the magnets. They should consult physicians to determine if it’s possible to use another mask for their therapy. In the meantime, they should switch to a non-magnetic mask if available.

Patients may continue to use the masks according to Philips’ updated instructions and labeling if patients or people in close proximity to them do not have implanted metallic medical devices or metallic objects in the body.

Reports of problems included suggestions of pacemaker interference, pacemaker failure leading to replacement, the need of shunt adjustment, resetting of an automatic implantable cardioverter defibrillator (AICD), seizures, defibrillator shutting off periodically, arrhythmia, irregular blood pressure, change in heartbeats, and cognitive issues.

The masks include magnets with a magnetic field strength of 400 mT, Philips said in the initial recall notice. With the exception of the devices identified in the contraindication, ensure that the mask is kept at least 6 in. (approximately 15 cm) away from any other medical implants or medical devices potentially impacted by the magnetic fields to avoid possible effects from localized magnetic fields. This includes household members, caregivers, and bed partners that may be in close vicinity to patients that use the masks.

“We have stepped up our actions to further improve patient safety and quality, and we have taken the initiative to further strengthen the warnings and add contraindications specifically related to the magnetic headgear clips in certain of our sleep therapy masks that are commonly used in the sleep therapy devices industry,” said David Ferguson, business leader for Philips Respironics, in a prepared statement at the time. He added that the company is launching a broad awareness and education campaign regarding the safety of masks containing magnetic headgear clips.

Continued troubles at Philips Respironics

Philips Respironics has long been handling a massive, deadly recall of CPAP and BiPAP ventilators and other respiratory devices. It also held talks with federal prosecutors over its handling of the recall. Respiratory device problems stem from polyester-based polyurethane sound abatement foam that could break down. Foam particles could enter a device’s air pathway and cause a range of potential health problems and toxic, carcinogenic effects for the use

In September, Philips Respironics settled with the U.S. Department of Justice for $24.8 million over kickback allegations.

Philips already spent a year out of the respiratory devices market for due to the recall. Roy Jakobs, the company’s Connected Care chief businesses leader who has been in charge of the recall, is recently became CEO.

Implanted devices that may be affected:

  • Pacemakers
  • Implantable cardioverter defibrillators (ICDs)
  • Neurostimulators
  • Magnetic metallic implants/electrodes/valves placed in upper limbs, torso, or higher (i.e., neck and head)
  • Cerebral spinal fluid (CSF) shunts, for example, ventriculo peritoneal (VP) shunts
  • Aneurysm clips
  • Embolic coils
  • Intracranial aneurysm intravascular flow disruption devices
  • Metallic cranial plates, screws, burr hole covers, and bone substitute devices
  • Metallic splinters in the eye
  • Ocular implants (e.g., glaucoma implants, retinal implants)
  • Certain contact lenses with metal
  • Implants to restore hearing or balance that have an implanted magnet (such as cochlear implants, implanted bone conduction hearing devices, and auditory brainstem implants)
  • Magnetic denture attachments
  • Metallic gastrointestinal clips
  • Metallic stents (e.g., aneurysm, coronary, tracheobronchial, biliary)
  • Implantable ports and pumps (e.g., insulin pumps)
  • Hypoglossal nerve stimulators
  • Devices labeled as MR (magnetic resonance) unsafe
  • Magnetic metallic implants not labeled for MR or not evaluated for safety in a magnetic field

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), News Well, Recalls, Regulatory/Compliance, Respiratory Tagged With: Philips, Philips Respironics

More recent news

  • Medtronic earns CE mark for redo TAVI procedure
  • Natus Neuro launches BrainWatch AI-driven, point-of-care EEG
  • Boston Scientific has positive real-world Acurate Prime TAVI data
  • Johnson & Johnson MedTech launches ultrasound catheter for imaging in cardiac ablation procedures
  • Onward reports more successful BCI implants

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy